Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,797,354
  • Shares Outstanding, K 41,731
  • Annual Sales, $ 337,280 K
  • Annual Income, $ -470 K
  • 60-Month Beta 1.13
  • Price/Sales 5.31
  • Price/Cash Flow 44.90
  • Price/Book 5.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.19
  • Number of Estimates 6
  • High Estimate 0.28
  • Low Estimate 0.10
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -32.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.25 +15.22%
on 11/07/19
45.18 -5.00%
on 11/08/19
+4.07 (+10.48%)
since 10/18/19
3-Month
34.64 +23.90%
on 09/09/19
45.18 -5.00%
on 11/08/19
+5.02 (+13.25%)
since 08/19/19
52-Week
34.64 +23.90%
on 09/09/19
50.30 -14.67%
on 12/04/18
-3.16 (-6.86%)
since 11/19/18

Most Recent Stories

More News
Pacira BioSciences to Present at the Jefferies 2019 London Healthcare Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the Jefferies 2019 London Healthcare Conference at 2:40 PM GMT (9:40AM ET) on Wednesday, November 20, 2019. Live audio of...

PCRX : 42.92 (-0.35%)
Pacira's (PCRX) Q3 Earnings Top Estimates, Revenues Rise Y/Y

Pacira's (PCRX) third-quarter results reflect an earnings beat while revenues almost match estimates. Exparel drives year-over-year growth.

JNJ : 134.82 (-0.01%)
TRIL : 0.28 (+6.91%)
PTLA : 29.17 (+3.99%)
PCRX : 42.92 (-0.35%)
Pacira (PCRX) Q3 Earnings Surpass Estimates

Pacira (PCRX) delivered earnings and revenue surprises of 41.18% and -0.33%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 42.92 (-0.35%)
Pacira: 3Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $6.1 million in its third quarter.

PCRX : 42.92 (-0.35%)
Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update

-- Total revenues increased 25 percent over prior year to $104.7 million in third quarter --

PCRX : 42.92 (-0.35%)
Small Step Back Ahead of Fed, Apple

Small Step Back Ahead of Fed, Apple

PODD : 180.89 (-0.88%)
LNG : 59.80 (-1.16%)
PCRX : 42.92 (-0.35%)
TSLA : 359.52 (+2.72%)
AMZN : 1,752.79 (+0.01%)
BIDU : 115.69 (-0.71%)
OXY : 38.14 (-2.95%)
PTC : 73.50 (+0.95%)
GRUB : 40.06 (-2.27%)
QUOT : 10.53 (-3.04%)
ERII : 8.53 (-2.18%)
JAZZ : 138.90 (+0.20%)
MTH : 70.86 (-1.36%)
Pacira to Report Third Quarter 2019 Financial Results on Thursday November 7, 2019

Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday, November 7, 2019. Following the release,...

PCRX : 42.92 (-0.35%)
% Return Seen to Date on SmarTrend Pacira Pharmaceu Call (PCRX)

SmarTrend identified a Downtrend for Pacira Pharmaceu (NASDAQ:PCRX) on September 25th, 2019 at $39.26. In approximately 4 weeks, Pacira Pharmaceu has returned 1.03% as of today's recent price of $38.85....

PCRX : 42.92 (-0.35%)
Lannett Co Inc is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (LCI , PCRX , DERM , BMY , HZNP )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 8.05 (+4.55%)
LCI : 9.00 (-0.33%)
PCRX : 42.92 (-0.35%)
Look for Shares of Pacira Pharmaceu to Potentially Pullback after Yesterday's 2.11% Rise

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $38.38 to a high of $39.81. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high...

PCRX : 42.92 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade PCRX with:

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

2nd Resistance Point 43.89
1st Resistance Point 43.41
Last Price 42.92
1st Support Level 42.52
2nd Support Level 42.11

See More

52-Week High 50.30
Fibonacci 61.8% 44.32
Last Price 42.92
Fibonacci 50% 42.47
Fibonacci 38.2% 40.62
52-Week Low 34.64

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar